Breast cancer screening controversies: Who, when, why, and how?

Clinical Imaging

Volumn 40, Issue 2, 2016, Pages 279-282

  Chetlen, Alison ^a   Mack, Julie ^a   Chan, Tiffany ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Automated whole breast ultrasound; Breast cancer screening; Magnetic resonance imaging; Mammography; Tomosynthesis

Indexed keywords

DISEASES; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; TOMOGRAPHY;

BREAST CANCER DIAGNOSIS; BREAST CANCER SCREENING; BREAST ULTRASOUND; FALSE NEGATIVE RATE; FALSE POSITIVE RATES; MOLECULAR BREAST IMAGING; OPTIMAL IMAGING MODALITY; TOMOSYNTHESIS;

MEDICAL IMAGING;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; DIGITAL BREAST TOMOSYNTHESIS; DIGITAL IMAGING; ECHOMAMMOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; MAMMOGRAPHY; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERDIAGNOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY; BREAST; BREAST NEOPLASMS; EARLY CANCER DIAGNOSIS; FEMALE; PATHOLOGY; PROCEDURES; RISK ASSESSMENT;

BREAST; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; RISK ASSESSMENT; ULTRASONOGRAPHY, MAMMARY;

EID: 84960805807     PISSN: 08997071     EISSN: 18734499     Source Type: Journal    
DOI: 10.1016/j.clinimag.2015.05.017     Document Type: Article

References (71)

1. Breast cancer estimated incidence mortality and prevalence worldwide in 2012 Available from:. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
2. Tabár L, Vitak B, Chen TH-H, Yen AM-F, Cohen A, Tot T, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 2011, 260(3):658-663.
3. Screening IUPoBC The benefits and harms of breast cancer screening: an independent review. Lancet 2012, 380(9855):1778-1786.
4. Gøtzsche PC, Jørgensen KJ Screening for breast cancer with mammography 2013, The Cochrane Library.
5. Tabar L, Gad A, Holmberg L, Ljungquist U, Group KCP, Fagerberg C, et al. Reduction in mortality from breast cancer after mass screening with mammography: randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985, 325(8433):829-832.
6. Shapiro S, Venet W, Strax P, Venet L, Roeser R Ten-to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982, 69(2):349-355.
7. Bleyer A, Welch HG Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012, 367(21):1998-2005.
8. Komenaka IK, Nodora JN, Hsu C-H, Martinez ME, Gandhi SG, Bouton ME, et al. Association of health literacy with adherence to screening mammography guidelines. Presented at the San Antonio Breast Cancer Symposium 2011.
9. Rahman SM, Dignan MB, Shelton BJ Factors influencing adherence to guidelines for screening mammography among women aged 40 years and older. Ethn Dis 2003, 13(4):477-484.
10. Rosenberg RD, Hunt WC, Williamson MR, Gilliland FD, Wiest PW, Kelsey CA, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology 1998, 209(2):511-518.
11. Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. Obstet Gynecol Surv 2006, 61(3):1773-1783.
12. Force UPST Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2009, 151(10):716-726.
13. Kopans DB, Moore RH, McCarthy KA, Hall DA, Hulka C, Whitman GJ, et al. Biasing the interpretation of mammography screening data by age grouping: nothing changes abruptly at age 50. Breast J 1998, 4(3):139-145.
14. Kalager M, Zelen M, Langmark F, Adami H-O Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 2010, 363(13):1203-1210.
15. Kopans DB Point: The New England Journal of Medicine article suggesting overdiagnosis from mammography screening is scientifically incorrect and should be withdrawn. J Am Coll Radiol 2013, 10(5):317-319.
16. Duffy S, Tabár L, Smith RA The mammographic screening trials: commentary on the recent work by Olsen and Gøtzsche. J Surg Oncol 2002, 81(4):159-162.
17. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 2014, 348. 10.1136/bmj.g366.
18. Miller AB, Baines CJ, To T, Wall C Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ 1992, 147(10):1459-1476.
19. Miller AB, Baines CJ, To T, Wall C Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 1992, 147(10):1477-1488.
20. Coldman A, Phillips N, Wilson C, Decker K, Chiarelli AM, Brisson J, et al. Pan-Canadian study of mammography screening and mortality from breast cancer. J Natl Cancer Inst 2014, 106(11):dju261. 10.1093/jnci/dju261.
21. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med 2009, 151(10):727-737.
22. Paci E Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen 2012, 19(Suppl 1):5-13.
23. Duffy SW, Chen TH-H, Smith RA, Yen AM-F, Tabar L Real and artificial controversies in breast cancer screening. Breast Cancer Manag 2013, 2(6):519-528.
24. Puliti D, Duffy SW, Miccinesi G, De Koning H, Lynge E, Zappa M, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 2012, 19(Suppl 1):42-56.
25. Jørgensen KJ, Gøtzsche PC Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009, 339:b2587.
26. Kalager M, Adami H-O, Bretthauer M, Tamimi RM Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med 2012, 156(7):491-499.
27. Etzioni R, Xia J, Hubbard R, Weiss NS, Gulati R A reality check for overdiagnosis estimates associated with breast cancer screening. J Natl Cancer Inst 2014, 106(12):dju315.
28. Duffy SW, Parmar D Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time. Breast Cancer Res 2013, 15(3):R41.
29. Yen M-F, Tabar L, Vitak B, Smith R, Chen H-H, Duffy S Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer 2003, 39(12):1746-1754.
30. Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ 2000, 320(7250):1635-1640.
31. Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH The randomized trials of breast cancer screening: what have we learned?. Radiol Clin N Am 2004, 42(5):793-806.
32. Hellquist BN, Duffy SW, Abdsaleh S, Björneld L, Bordás P, Tabar L, et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years. Cancer 2011, 117(4):714-722.
33. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005, 353(17):1784-1792.
34. Pashayan N, Duffy SW, Chowdhury S, Dent T, Burton H, Neal DE, et al. Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer 2011, 104(10):1656-1663.
35. Meeting F Breast-cancer screening with mammography in women aged 40-49 years. Int J Cancer 1996, 68(6):693-699.
36. Kerlikowske K Screening mammography in women less than age 50 years. Curr Opin Obstet Gynecol 2012, 24(1):38-43.
37. Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 1993, 270(20):2444-2450.
38. Duffy S, Tabar L, Olsen A, Vitak B, Allgood P, Chen T, et al. Cancer mortality in the 50-69 year age group before and after screening. J Med Screen 2010, 17(3):159-160.
39. Jensena A, Ewertz M, Cold S, Storm H, Overgaard J Time trends and regional differences in registration, stage distribution, surgical management and survival of breast cancer in Denmark. Eur J Cancer 2003, 39(12):1783-1793.
40. Chen TH, Jonsson SH, Lenner P Effect of mammographic service screening on stage at presentation of breast cancers in Sweden. Cancer 2007, 109(11):2205-2212.
41. Altekruse S, Kosary C, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER cancer statistics review, 1975-2007 2010, 7. National Cancer Institute, Bethesda, MD.
42. Surveillance, Epidemiology, and End Results (SEER) Program Available from:. http://www.seer.cancer.gov.
43. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006, 56(2):106-130.
44. Friedewald SM, Rafferty EA, Rose SL, Durand MA, Plecha DM, Greenberg JS, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA 2014, 311(24):2499-2507.
45. Skaane P, Bandos AI, Gullien R, Eben EB, Ekseth U, Haakenaasen U, et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology 2013, 267(1):47-56.
46. Ciatto S, Houssami N, Bernardi D, Caumo F, Pellegrini M, Brunelli S, et al. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Lancet Oncol 2013, 14(7):583-589.
47. Rose SL, Tidwell AL, Bujnoch LJ, Kushwaha AC, Nordmann AS, Sexton R Implementation of breast tomosynthesis in a routine screening practice: an observational study. Am J Roentgenol 2013, 200(6):1401-1408.
48. Kim SA, Chang JM, Cho N, Yi A, Moon WK Characterization of breast lesions: comparison of digital breast tomosynthesis and ultrasonography. Korean J Radiol 2015, 16:229-238.
49. Benson S, Blue J, Judd K, Harman J Ultrasound is now better than mammography for the detection of invasive breast cancer. Am J Surg 2004, 188(4):381-385.
50. Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer 1. Radiology 2004, 233(3):830-849.
51. Crystal P, Strano SD, Shcharynski S, Koretz MJ Using sonography to screen women with mammographically dense breasts. Am J Roentgenol 2003, 181(1):177-182.
52. Kaplan SS Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue 1. Radiology 2001, 221(3):641-649.
53. Kolb TM, Lichy J, Newhouse JH Occult cancer in women with dense breasts: detection with screening US-diagnostic yield and tumor characteristics. Radiology 1998, 207(1):191-199.
54. Kolb TM, Lichy J, Newhouse JH Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations 1. Radiology 2002, 225(1):165-175.
55. Leconte I, Feger C, Galant C, Berlière M, Berg BV, D'Hoore W, et al. Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density. Am J Roentgenol 2003, 180(6):1675-1679.
56. Moon WK, Noh D-Y, Im J-G Multifocal, multicentric, and contralateral breast cancers: bilateral whole-breast US in the preoperative evaluation of patients 1. Radiology 2002, 224(2):569-576.
57. Kelly KM, Dean J, Comulada WS, Lee S-J Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. Eur Radiol 2010, 20(3):734-742.
58. Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Böhm-Vélez M, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 2008, 299(18):2151-2163.
59. Giuliano V, Giuliano C Improved breast cancer detection in asymptomatic women using 3D-automated breast ultrasound in mammographically dense breasts. Clin Imaging 2013, 37(3):480-486.
60. Brem RF, Tabár L, Duffy SW, Inciardi MF, Guingrich JA, Hashimoto BE, et al. Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: The SomoInsight Study. Radiology 2014, 274(3):663-673.
61. Weigert J, Steenbergen S The Connecticut experiment: the role of ultrasound in the screening of women with dense breasts. Breast J 2012, 18(6):517-522.
62. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007, 57(2):75-89.
63. Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005, 23(33):8469-8476.
64. Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004, 351(5):427-437.
65. Leach MO, Boggis C, Dixon A, Easton D, Eeles R, Evans D, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005, 365(9473):1769-1778.
66. Sardanelli F, Podo F Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection?. Eur Radiol 2007, 17(4):873-887.
67. Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004, 292(11):1317-1325.
68. Brem RF, Rapelyea JA, Zisman G, Mohtashemi K, Raub J, Teal CB, et al. Occult breast cancer: scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer 1. Radiology 2005, 237(1):274-280.
69. Brem RF, Floerke AC, Rapelyea JA, Teal C, Kelly T, Mathur V Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer 1. Radiology 2008, 247(3):651-657.
70. Tadwalkar R, Rapelyea J, Torrente J, Rechtman L, Teal C, McSwain A, et al. Breast-specific gamma imaging as an adjunct modality for the diagnosis of invasive breast cancer with correlation to tumour size and grade. Breast 2014, 85(1014):e-212-e216.
71. Brem RF, Petrovitch I, Rapelyea JA, Young H, Teal C, Kelly T Breast-specific gamma imaging with 99mTc-Sestamibi and magnetic resonance imaging in the diagnosis of breast cancer-a comparative study. Breast J 2007, 13(5):465-469.